APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Autoimmunity Reagents

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

Selected research

Market Structure

Global Autoimmunity Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173968380328 December 2025196 pages

Choose your research edition.

Industry ResearchAutoimmunity Reagents Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmunity Reagents Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Autoimmunity Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmunity Reagents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmunity Reagents Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.

EUROIMMUN、HUMAN、Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.

Read the full market overview

This report provides an overview of the global Autoimmunity Reagents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autoimmunity Reagents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autoimmunity Reagents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Autoimmunity Reagents market size, projected growth trends, production technologies, key applications, and end-use industries.

Autoimmunity Reagents Segment by Company

EUROIMMUN

HUMAN

Bio-Rad Laboratories

AESKU

Inova

MBL

Orgentec

Trinity

Phadia

HOB Biotech

Shenzhen YHLO Biotech

Kangrun Biotech

Immuno-Biological Laboratories

Biomedical diagnostics

Shanghai Kexin

Autoimmunity Reagents Segment by Type

BLOT

ELISA

IFA

CLIA

Autoimmunity Reagents Segment by Application

Hospital

Third-Party Testing Agency

Autoimmunity Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmunity Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmunity Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmunity Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Autoimmunity Reagents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Autoimmunity Reagents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Autoimmunity Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Autoimmunity Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Autoimmunity Reagents Industry Trends Table 2. Autoimmunity Reagents Industry Drivers Table 3. Autoimmunity Reagents Industry Opportunities and Challenges Table 4. Autoimmunity Reagents Industry Restraints Table 5. Global Autoimmunity Reagents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Autoimmunity Reagents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Autoimmunity Reagents Sales by Manufacturers (K Unit) & (2021-2026) Table 8. Global Autoimmunity Reagents Sales Market Share by Manufacturers Table 9. Global Autoimmunity Reagents Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Autoimmunity Reagents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Autoimmunity Reagents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Autoimmunity Reagents Manufacturers, Product Type & Application Table 13. Global Autoimmunity Reagents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Autoimmunity Reagents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BLOT Table 17. Major Manufacturers of ELISA Table 18. Major Manufacturers of IFA Table 19. Major Manufacturers of CLIA Table 20. Global Autoimmunity Reagents Sales by Type 2021 VS 2025 VS 2032 (K Unit) Table 21. Global Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 22. Global Autoimmunity Reagents Sales by Type (2027-2032) & (K Unit) Table 23. Global Autoimmunity Reagents Sales Market Share by Type (2021-2026) Table 24. Global Autoimmunity Reagents Sales Market Share by Type (2027-2032) Table 25. Global Autoimmunity Reagents Revenue by Type 2021 VS 2025 VS 2032 (K Unit) Table 26. Global Autoimmunity Reagents Revenue by Type (2021-2026) & (K Unit) Table 27. Global Autoimmunity Reagents Revenue by Type (2027-2032) & (K Unit) Table 28. Global Autoimmunity Reagents Revenue Market Share by Type (2021-2026) Table 29. Global Autoimmunity Reagents Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Third-Party Testing Agency Table 32. Global Autoimmunity Reagents Sales by Application 2021 VS 2025 VS 2032 (K Unit) Table 33. Global Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 34. Global Autoimmunity Reagents Sales by Application (2027-2032) & (K Unit) Table 35. Global Autoimmunity Reagents Sales Market Share by Application (2021-2026) Table 36. Global Autoimmunity Reagents Sales Market Share by Application (2027-2032) Table 37. Global Autoimmunity Reagents Revenue by Application 2021 VS 2025 VS 2032 (K Unit) Table 38. Global Autoimmunity Reagents Revenue by Application (2021-2026) & (K Unit) Table 39. Global Autoimmunity Reagents Revenue by Application (2027-2032) & (K Unit) Table 40. Global Autoimmunity Reagents Revenue Market Share by Application (2021-2026) Table 41. Global Autoimmunity Reagents Revenue Market Share by Application (2027-2032) Table 42. Global Autoimmunity Reagents Sales by Region: 2021 VS 2025 VS 2032 (K Unit) Table 43. Global Autoimmunity Reagents Sales by Region (2021-2026) & (K Unit) Table 44. Global Autoimmunity Reagents Sales Market Share by Region (2021-2026) Table 45. Global Autoimmunity Reagents Sales Forecasted by Region (2027-2032) & (K Unit) Table 46. Global Autoimmunity Reagents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 48. North America Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 49. North America Autoimmunity Reagents Sales by Country (2027-2032) & (K Unit) Table 50. Europe Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 51. Europe Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 52. Europe Autoimmunity Reagents Sales by Country (2027-2032) & (K Unit) Table 53. Asia Pacific Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 54. Asia Pacific Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 55. Asia Pacific Autoimmunity Reagents Sales by Country (2027-2032) & (K Unit) Table 56. South America, Middle East and Africa Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 57. South America, Middle East and Africa Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 58. South America, Middle East and Africa Autoimmunity Reagents Sales by Country (2027-2032) & (K Unit) Table 59. Global Autoimmunity Reagents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Autoimmunity Reagents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Autoimmunity Reagents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Autoimmunity Reagents Revenue Market Share by Region (2021-2026) Table 63. Global Autoimmunity Reagents Revenue Market Share by Region (2027-2032) Table 64. EUROIMMUN Company Information Table 65. EUROIMMUN Business Overview Table 66. EUROIMMUN Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. EUROIMMUN Autoimmunity Reagents Product Portfolio Table 68. EUROIMMUN Recent Development Table 69. HUMAN Company Information Table 70. HUMAN Business Overview Table 71. HUMAN Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. HUMAN Autoimmunity Reagents Product Portfolio Table 73. HUMAN Recent Development Table 74. Bio-Rad Laboratories Company Information Table 75. Bio-Rad Laboratories Business Overview Table 76. Bio-Rad Laboratories Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio Table 78. Bio-Rad Laboratories Recent Development Table 79. AESKU Company Information Table 80. AESKU Business Overview Table 81. AESKU Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AESKU Autoimmunity Reagents Product Portfolio Table 83. AESKU Recent Development Table 84. Inova Company Information Table 85. Inova Business Overview Table 86. Inova Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Inova Autoimmunity Reagents Product Portfolio Table 88. Inova Recent Development Table 89. MBL Company Information Table 90. MBL Business Overview Table 91. MBL Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MBL Autoimmunity Reagents Product Portfolio Table 93. MBL Recent Development Table 94. Orgentec Company Information Table 95. Orgentec Business Overview Table 96. Orgentec Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Orgentec Autoimmunity Reagents Product Portfolio Table 98. Orgentec Recent Development Table 99. Trinity Company Information Table 100. Trinity Business Overview Table 101. Trinity Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Trinity Autoimmunity Reagents Product Portfolio Table 103. Trinity Recent Development Table 104. Phadia Company Information Table 105. Phadia Business Overview Table 106. Phadia Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Phadia Autoimmunity Reagents Product Portfolio Table 108. Phadia Recent Development Table 109. HOB Biotech Company Information Table 110. HOB Biotech Business Overview Table 111. HOB Biotech Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. HOB Biotech Autoimmunity Reagents Product Portfolio Table 113. HOB Biotech Recent Development Table 114. Shenzhen YHLO Biotech Company Information Table 115. Shenzhen YHLO Biotech Business Overview Table 116. Shenzhen YHLO Biotech Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio Table 118. Shenzhen YHLO Biotech Recent Development Table 119. Kangrun Biotech Company Information Table 120. Kangrun Biotech Business Overview Table 121. Kangrun Biotech Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Kangrun Biotech Autoimmunity Reagents Product Portfolio Table 123. Kangrun Biotech Recent Development Table 124. Immuno-Biological Laboratories Company Information Table 125. Immuno-Biological Laboratories Business Overview Table 126. Immuno-Biological Laboratories Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio Table 128. Immuno-Biological Laboratories Recent Development Table 129. Biomedical diagnostics Company Information Table 130. Biomedical diagnostics Business Overview Table 131. Biomedical diagnostics Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Biomedical diagnostics Autoimmunity Reagents Product Portfolio Table 133. Biomedical diagnostics Recent Development Table 134. Shanghai Kexin Company Information Table 135. Shanghai Kexin Business Overview Table 136. Shanghai Kexin Autoimmunity Reagents Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Shanghai Kexin Autoimmunity Reagents Product Portfolio Table 138. Shanghai Kexin Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Autoimmunity Reagents Distributors List Table 142. Autoimmunity Reagents Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Autoimmunity Reagents Product Image Figure 2. Global Autoimmunity Reagents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autoimmunity Reagents Market Size (2021-2032) & (US$ Million) Figure 4. Global Autoimmunity Reagents Sales (2021-2032) & (K Unit) Figure 5. Global Autoimmunity Reagents Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Autoimmunity Reagents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BLOT Image Figure 9. ELISA Image Figure 10. IFA Image Figure 11. CLIA Image Figure 12. Global Autoimmunity Reagents Sales by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 13. Global Autoimmunity Reagents Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Autoimmunity Reagents Sales Market Share by Type (2021-2032) Figure 15. Global Autoimmunity Reagents Revenue by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 16. Global Autoimmunity Reagents Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Autoimmunity Reagents Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Third-Party Testing Agency Image Figure 20. Global Autoimmunity Reagents Sales by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 21. Global Autoimmunity Reagents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Autoimmunity Reagents Sales Market Share by Application (2021-2032) Figure 23. Global Autoimmunity Reagents Revenue by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 24. Global Autoimmunity Reagents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Autoimmunity Reagents Revenue Market Share by Application (2021-2032) Figure 26. North America Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 27. North America Autoimmunity Reagents Sales Market Share by Country (2021-2032) Figure 28. U.S. Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 29. Canada Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 30. Mexico Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 31. Europe Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 32. Europe Autoimmunity Reagents Sales Market Share by Country (2021-2032) Figure 33. Germany Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 34. France Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 35. U.K. Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 36. Italy Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 37. Netherlands Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 38. Asia Pacific Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 39. Asia Pacific Autoimmunity Reagents Sales Market Share by Country (2021-2032) Figure 40. China Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 41. Japan Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 42. South Korea Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 43. Southeast Asia Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 44. India Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 45. Australia Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 46. South America, Middle East and Africa Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 47. South America, Middle East and Africa Autoimmunity Reagents Sales Market Share by Country (2021-2032) Figure 48. Brazil Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 49. South Africa Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 50. Saudi Arabia Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 51. Turkey Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 52. Argentina Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 53. UAE Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 54. Egypt Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 55. Chile Autoimmunity Reagents Sales and Growth Rate (2021-2032) & (K Unit) Figure 56. Global Autoimmunity Reagents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Autoimmunity Reagents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Autoimmunity Reagents Revenue (2021-2032) & (US$ Million) Figure 59. North America Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Autoimmunity Reagents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Autoimmunity Reagents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Autoimmunity Reagents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Autoimmunity Reagents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Autoimmunity Reagents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • BLOT
  • ELISA
  • IFA
  • CLIA
Applications
  • Hospital
  • Third-Party Testing Agency
Companies covered
  • EUROIMMUN
  • HUMAN
  • Bio-Rad Laboratories
  • AESKU
  • Inova
  • MBL
  • Orgentec
  • Trinity
  • Phadia
  • HOB Biotech
  • Shenzhen YHLO Biotech
  • Kangrun Biotech
  • Immuno-Biological Laboratories
  • Biomedical diagnostics
  • Shanghai Kexin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Autoimmunity Reagents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Autoimmunity Reagents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Autoimmunity Reagents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Autoimmunity Reagents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Autoimmunity Reagents Market Dynamics
  1. 2.1 Autoimmunity Reagents Industry Trends
  2. 2.2 Autoimmunity Reagents Industry Drivers
  3. 2.3 Autoimmunity Reagents Industry Opportunities and Challenges
  4. 2.4 Autoimmunity Reagents Industry Restraints
3 Autoimmunity Reagents Market by Manufacturers
  1. 3.1 Global Autoimmunity Reagents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Autoimmunity Reagents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Autoimmunity Reagents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Autoimmunity Reagents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Autoimmunity Reagents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Autoimmunity Reagents Manufacturers, Product Type & Application
  7. 3.7 Global Autoimmunity Reagents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Autoimmunity Reagents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Autoimmunity Reagents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Autoimmunity Reagents Tier 1, Tier 2, and Tier 3
4 Autoimmunity Reagents Market by Type
  1. 4.1 Autoimmunity Reagents Type Introduction
  2. 4.1.1 BLOT
  3. 4.1.2 ELISA
  4. 4.1.3 IFA
  5. 4.1.4 CLIA
  6. 4.2 Global Autoimmunity Reagents Sales by Type
  7. 4.2.1 Global Autoimmunity Reagents Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Autoimmunity Reagents Sales by Type (2021-2032)
  9. 4.2.3 Global Autoimmunity Reagents Sales Market Share by Type (2021-2032)
  10. 4.3 Global Autoimmunity Reagents Revenue by Type
  11. 4.3.1 Global Autoimmunity Reagents Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Autoimmunity Reagents Revenue by Type (2021-2032)
  13. 4.3.3 Global Autoimmunity Reagents Revenue Market Share by Type (2021-2032)
5 Autoimmunity Reagents Market by Application
  1. 5.1 Autoimmunity Reagents Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Third-Party Testing Agency
  4. 5.2 Global Autoimmunity Reagents Sales by Application
  5. 5.2.1 Global Autoimmunity Reagents Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Autoimmunity Reagents Sales by Application (2021-2032)
  7. 5.2.3 Global Autoimmunity Reagents Sales Market Share by Application (2021-2032)
  8. 5.3 Global Autoimmunity Reagents Revenue by Application
  9. 5.3.1 Global Autoimmunity Reagents Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Autoimmunity Reagents Revenue by Application (2021-2032)
  11. 5.3.3 Global Autoimmunity Reagents Revenue Market Share by Application (2021-2032)
6 Global Autoimmunity Reagents Sales by Region
  1. 6.1 Global Autoimmunity Reagents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Autoimmunity Reagents Sales by Region (2021-2032)
  3. 6.2.1 Global Autoimmunity Reagents Sales by Region (2021-2026)
  4. 6.2.2 Global Autoimmunity Reagents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Autoimmunity Reagents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Autoimmunity Reagents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Autoimmunity Reagents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Autoimmunity Reagents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Autoimmunity Reagents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Autoimmunity Reagents Revenue by Region
  1. 7.1 Global Autoimmunity Reagents Revenue by Region
  2. 7.1.1 Global Autoimmunity Reagents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Autoimmunity Reagents Revenue by Region (2021-2026)
  4. 7.1.3 Global Autoimmunity Reagents Revenue by Region (2027-2032)
  5. 7.1.4 Global Autoimmunity Reagents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Autoimmunity Reagents Revenue (2021-2032)
  8. 7.2.2 North America Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Autoimmunity Reagents Revenue (2021-2032)
  11. 7.3.2 Europe Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Autoimmunity Reagents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Autoimmunity Reagents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Autoimmunity Reagents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 EUROIMMUN
  2. 8.1.1 EUROIMMUN Company Information
  3. 8.1.2 EUROIMMUN Business Overview
  4. 8.1.3 EUROIMMUN Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 EUROIMMUN Autoimmunity Reagents Product Portfolio
  6. 8.1.5 EUROIMMUN Recent Developments
  7. 8.2 HUMAN
  8. 8.2.1 HUMAN Company Information
  9. 8.2.2 HUMAN Business Overview
  10. 8.2.3 HUMAN Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HUMAN Autoimmunity Reagents Product Portfolio
  12. 8.2.5 HUMAN Recent Developments
  13. 8.3 Bio-Rad Laboratories
  14. 8.3.1 Bio-Rad Laboratories Company Information
  15. 8.3.2 Bio-Rad Laboratories Business Overview
  16. 8.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio
  18. 8.3.5 Bio-Rad Laboratories Recent Developments
  19. 8.4 AESKU
  20. 8.4.1 AESKU Company Information
  21. 8.4.2 AESKU Business Overview
  22. 8.4.3 AESKU Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AESKU Autoimmunity Reagents Product Portfolio
  24. 8.4.5 AESKU Recent Developments
  25. 8.5 Inova
  26. 8.5.1 Inova Company Information
  27. 8.5.2 Inova Business Overview
  28. 8.5.3 Inova Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Inova Autoimmunity Reagents Product Portfolio
  30. 8.5.5 Inova Recent Developments
  31. 8.6 MBL
  32. 8.6.1 MBL Company Information
  33. 8.6.2 MBL Business Overview
  34. 8.6.3 MBL Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MBL Autoimmunity Reagents Product Portfolio
  36. 8.6.5 MBL Recent Developments
  37. 8.7 Orgentec
  38. 8.7.1 Orgentec Company Information
  39. 8.7.2 Orgentec Business Overview
  40. 8.7.3 Orgentec Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Orgentec Autoimmunity Reagents Product Portfolio
  42. 8.7.5 Orgentec Recent Developments
  43. 8.8 Trinity
  44. 8.8.1 Trinity Company Information
  45. 8.8.2 Trinity Business Overview
  46. 8.8.3 Trinity Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Trinity Autoimmunity Reagents Product Portfolio
  48. 8.8.5 Trinity Recent Developments
  49. 8.9 Phadia
  50. 8.9.1 Phadia Company Information
  51. 8.9.2 Phadia Business Overview
  52. 8.9.3 Phadia Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Phadia Autoimmunity Reagents Product Portfolio
  54. 8.9.5 Phadia Recent Developments
  55. 8.10 HOB Biotech
  56. 8.10.1 HOB Biotech Company Information
  57. 8.10.2 HOB Biotech Business Overview
  58. 8.10.3 HOB Biotech Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HOB Biotech Autoimmunity Reagents Product Portfolio
  60. 8.10.5 HOB Biotech Recent Developments
  61. 8.11 Shenzhen YHLO Biotech
  62. 8.11.1 Shenzhen YHLO Biotech Company Information
  63. 8.11.2 Shenzhen YHLO Biotech Business Overview
  64. 8.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio
  66. 8.11.5 Shenzhen YHLO Biotech Recent Developments
  67. 8.12 Kangrun Biotech
  68. 8.12.1 Kangrun Biotech Company Information
  69. 8.12.2 Kangrun Biotech Business Overview
  70. 8.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kangrun Biotech Autoimmunity Reagents Product Portfolio
  72. 8.12.5 Kangrun Biotech Recent Developments
  73. 8.13 Immuno-Biological Laboratories
  74. 8.13.1 Immuno-Biological Laboratories Company Information
  75. 8.13.2 Immuno-Biological Laboratories Business Overview
  76. 8.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio
  78. 8.13.5 Immuno-Biological Laboratories Recent Developments
  79. 8.14 Biomedical diagnostics
  80. 8.14.1 Biomedical diagnostics Company Information
  81. 8.14.2 Biomedical diagnostics Business Overview
  82. 8.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biomedical diagnostics Autoimmunity Reagents Product Portfolio
  84. 8.14.5 Biomedical diagnostics Recent Developments
  85. 8.15 Shanghai Kexin
  86. 8.15.1 Shanghai Kexin Company Information
  87. 8.15.2 Shanghai Kexin Business Overview
  88. 8.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shanghai Kexin Autoimmunity Reagents Product Portfolio
  90. 8.15.5 Shanghai Kexin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Autoimmunity Reagents Value Chain Analysis
  2. 9.1.1 Autoimmunity Reagents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Autoimmunity Reagents Production Mode & Process
  6. 9.2 Autoimmunity Reagents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Autoimmunity Reagents Distributors
  9. 9.2.3 Autoimmunity Reagents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst